BridgeMD
New treatment option for Posttraumatic Stress Disorder
Official title Piloting Virtual Reality Environments to Treat PTSD in Healthcare Workers
ClinicalTrials.gov ID: NCT04887116
What this study is testing
- What it's testing
- Healthcare workers and COVID-19 patients may experience psychological distress consequent to the pandemic, and are at particularly elevated risk for experiencing posttraumatic stress disorder (PTSD), based on evidence from previous infectious disease outbreaks. The best-validated treatment for PTSD is exposure therapy.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- A COVID-19 patient or any healthcare worker providing medical care or support who experiences occupational-related trauma
- English-speaking
- Age ≥18
- Medically stable
- Diagnosed with PTSD or sub threshold PTSD
You likely can't join if
- Current significant unstable medical illness such that the participant could not attend sessions regularly or complete assessments
- Patients who in the investigator's judgment pose a current homicidal, suicidal or other risk
- Lifetime or Current diagnosis of schizophrenia or other psychotic disorder
- Participation in a clinical trial or concurrent evidence-based treatment for psychiatric conditions or PTSD during the previous 3 months
- History of motion sickness or seizures
See the full eligibility criteria
- A COVID-19 patient or any healthcare worker providing medical care or support who experiences occupational-related trauma
- English-speaking
- Age ≥18
- Medically stable
- Diagnosed with PTSD or sub threshold PTSD
- Ability to provide informed consent and function at an intellectual level sufficient to allow accurate completion of all assessment instruments
- Stable on psychotropic medication for the prior 60 days
- Current significant unstable medical illness such that the participant could not attend sessions regularly or complete assessments
- Patients who in the investigator's judgment pose a current homicidal, suicidal or other risk
- Lifetime or Current diagnosis of schizophrenia or other psychotic disorder
- Participation in a clinical trial or concurrent evidence-based treatment for psychiatric conditions or PTSD during the previous 3 months
- History of motion sickness or seizures
The study team makes the final eligibility decision.
Where it's taking place
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New York, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.